As filed with the Securities and Exchange Commission on October 26, 2005
                                  Reg. No. 333-

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM S-8

             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                                APO Health, Inc.
             (Exact name of registrant as specified in its charter)

           Nevada                                              86-0871787
(State or other jurisdiction of                             (I.R.S. Employer
incorporation or organization)                              identification No.)

                 3950 Oceanside Road, Oceanside, New York 11575
- --------------------------------------------------------------------------------
               (Address of principal executive offices) (Zip Code)

              2005 PROFESSIONAL/CONSULTANT STOCK COMPENSATION PLAN
                             (full time of the plan)

                                  Dr. Jan Stahl
                      President and Chief Executive Officer
- --------------------------------------------------------------------------------
                               3950 Oceanside Road
                            Oceanside, New York 11575
                     (Name and address of agent for service)

                                 (800) 365-2839
          (Telephone number, including area code, of agent for service)





                         CALCULATION OF REGISTRATION FEE
- --------------------------------------------------------------------------------------------------------------
                        Proposed maximum      Proposed maximum
                        Amount to be          offering price       Aggregate offering    Amount of
Title of securities     Registered            per share            Price                 Registration fee
to be registered
- ----------------------- --------------------- -------------------- --------------------- ---------------------
                                                                                   
Common Stock                 2,500,000 (1)         $0.022 (2)           $55,000.00              $6.47
($.0002 par value)
- ----------------------- --------------------- -------------------- --------------------- ---------------------


(1)  In addition,  pursuant to Rule 416(c) under the  Securities Act of 1933, as
     amended, this registration  statement also coves an indeterminate amount of
     interests    to   be    offered    or   sold    pursuant    to   the   2005
     Professional/Consultant Stock Compensation Plan described herein.

(2)  Estimated  solely  for the  purpose of  calculating  the  registration  fee
     pursuant to Rule 457(c) of the Securities Act of 1933, as amended, based on
     the average of the high and low prices  reported on the OTC Bulletin  Board
     on October 25, 2005, which was $0.022.



                                EXPLANATORY NOTE

     This  Registration  Statement  on Form S-8 relates to the issuance of up to
2,500,000 shares of common stock pursuant to the 2005(B) Professional/Consultant
Stock Compensation Plan of APO Health, Inc.


                                     PART I
              INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

     Information  required by Part I of Form S-8 to be contained in a prospectus
meeting the  requirements  of Section  10(a) of the  Securities  Act of 1933, as
amended (the "Securities  Act"), is not required to be filed with the Securities
and  Exchange  Commission  and is omitted  from this  registration  statement in
accordance with the  explanatory  note to Part I of Form S-8 and Rule 428 of the
Securities Act.

                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Reference.

     The Registrant  hereby  incorporates  by reference  into this  Registration
Statement the documents  listed below. In addition,  all documents  subsequently
filed pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange
Act of 1934  (the  "Exchange  Act"),  prior to the  filing  of a  post-effective
amendment  which  indicates that all securities  offered have been sold or which
deregisters  all  securities  then  remaining  unsold,  shall  be  deemed  to be
incorporated  by reference  into this  Registration  Statement  and to be a part
hereof from the date of filing of such documents:

     o    Reference is made to the  Registrant's  annual report on Form 10-K for
          the years ended  September  30, 2004,  2003 and 2002 as filed with the
          Securities  and Exchange  Commission  on December  28, 2004,  which is
          hereby incorporated by reference.

     o    Reference is made to the  Registrant's  quarterly  report on Form 10-Q
          for the three months ended June 30, 2005, as filed with the Securities
          and  Exchange   Commission  on  August  19,  2005,   which  is  hereby
          incorporated by reference.

     o    Reference is made to the  Registrant's  quarterly  report on Form 10-Q
          for the  three  months  ended  March  31,  2005,  as  filed  with  the
          Securities  and Exchange  Commission on May 23, 2005,  which is hereby
          incorporated by reference.

     o    Reference is made to the  Registrant's  quarterly  report on Form 10-Q
          for the three  months  ended  December  31,  2004,  as filed  with the
          Securities  and Exchange  Commission  on February  14, 2005,  which is
          hereby incorporated by reference.

     o    The  description of the  Registrant's  common stock is incorporated by
          reference to the Registrant's Registration Statement on Form 10-SB, as
          amended (File No. 000-30074),  initially filed with the Securities and
          Exchange Commission on February 19, 1999.

Item 4.  Description of Securities.

         Not applicable.

Item 5.  Interests of Named Experts and Counsel.

         Not applicable.

Item 6.  Indemnification of Directors and Officers.

                                       1


     Nevada  corporations  are  authorized  to indemnify  against  liability any
person who is a party to any legal proceeding  because such person is a director
or officer of the  corporation.  The officer or director  must act in good faith
and  in a  manner  reasonably  believed  to be in  the  best  interests  of  the
corporation  and,  with respect to any criminal  action or  proceeding,  have no
reasonable cause to believe the conduct was unlawful.  Nevada law does not allow
indemnification for an act or omission that involves intentional misconduct or a
knowing  violation  of a law.  In the case of an  action  by or on  behalf  of a
corporation,   indemnification   may  not  be  made   if  the   person   seeking
indemnification  is found  liable,  unless  the court in which  such  action was
brought   determines   such  person  is  fairly  and   reasonably   entitled  to
indemnification.  Indemnification  is required if a director or officer has been
successful on the merits.

     The indemnification  authorized under Nevada law is not exclusive and is in
addition to any other rights  granted to officers and  directors.  A corporation
may purchase and maintain  insurance or furnish similar  protection on behalf of
any officer or director.

     Our articles of incorporation  provide for the indemnification of directors
and executive officers to the maximum extent permitted by Nevada law. Insofar as
indemnification  for  liabilities  arising  under  the  Securities  Act  may  be
permitted to our  directors,  officers or  controlling  persons  pursuant to the
foregoing  provisions or otherwise,  we have been advised that in the opinion of
the Securities and Exchange  Commission such  indemnification  is against public
policy as expressed in the Securities Act and is therefore unenforceable.

     There  is  no  pending  litigation  or  proceeding  involving  any  of  our
directors, officers, employees or agents where indemnification would be required
or permitted.  We are not aware of any threatened  litigation or proceeding that
would result in a claim for such indemnification.

Item 7.  Exemption from Registration Claimed.

         Not Applicable.

Item 8.  Exhibits.

EXHIBIT
NUMBER         EXHIBIT
- -------        -------
4.1            APO Health,  Inc.  2005(B)  Professional/Consultant  Compensation
               Plan, dated October 15, 2005.

5.1            Opinion of Sichenzia Ross Friedman Ference LLP.

23.1           Consent of Sichenzia  Ross  Friedman  Ference LLP is contained in
               Exhibit 5.1.

23.2           Consent  of  Linder  &  Linder,   independent  registered  public
               accounting firm.

                                       2

Item 9.  Undertakings.

     (a) The undersigned registrant hereby undertakes:

          (1) To file,  during  any  period  in which  offers or sales are being
made, a post-effective amendment to this Registration Statement:

          To  include  any  material  information  with  respect  to the plan of
distribution  not  previously  disclosed  in the  Registration  Statement or any
material change to such information in the Registration Statement;

          (2) That,  for the  purpose of  determining  any  liability  under the
Securities Act of 1933, each such post-effective amendment shall be deemed to be
a new Registration Statement relating to the securities offered therein, and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

          (3) To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the termination of
the offering.

     (b) The  undersigned  registrant  hereby  undertakes  that, for purposes of
determining  any liability  under the Securities Act of 1933, each filing of the
registrant's  annual  report  pursuant to Section  13(a) or Section 15(d) of the
Securities  Exchange  Act of  1934  that is  incorporated  by  reference  in the
Registration  Statement  shall  be  deemed  to be a new  Registration  Statement
relating to the securities  offered herein,  and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

     (c) Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors,  officers and controlling  persons of
the  registrant  pursuant  to  the  foregoing  provisions,   or  otherwise,  the
registrant  has been advised that in the opinion of the  Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act
and is, therefore,  unenforceable. In the event that a claim for indemnification
against such  liabilities  (other than the payment by the registrant of expenses
incurred or paid by a director, officer, or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director,  officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been  settled by  controlling  precedent,  submit to a court of  appropriate
jurisdiction the question whether such  indemnification  by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.


                                       3

                                   SIGNATURES


     Pursuant to the  requirements of the Securities Act of 1933, the Registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  registration
statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized, in the City of Oceanside, State of New York on October 26, 2005.




                                     APO HEALTH, INC.


                                     By: /s/ Jan Stahl
                                         -------------
                                         Jan Stahl,
                                         Chairman, Chief Executive Officer,
                                         Acting Chief Financial Officer

Pursuant to the  requirements of the Securities Act of 1933,  this  registration
statement on Form S-8 has been signed by the following persons in the capacities
and on the date indicated:

 Signature                         Title                       Date

/s/ Jan Stahl                     Director               October 26, 2005
- -------------
Jan Stahl

/s/ Kenneth Leventhal             Director               October 26, 2005
- ---------------------
Kenneth Leventhal




                                       4